_risk-basics-for-medical-devices-preview-1.jpg "Risk Basics for Medical Devices from fda definition of medical device complaint Video Screenshot Preview 1")
Gallery_risk-basics-for-medical-devices-preview-3.jpg "Risk Basics for Medical Devices from fda definition of medical device complaint Video Screenshot Preview 3")
Gallery_risk-basics-for-medical-devices-preview-hqdefault.jpg "Risk Basics for Medical Devices from fda definition of medical device complaint Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 23 minutes 18 seconds
👁 View: 3.8K times
Play Audio:👁 View: 3.8K times
Description:
U.S. Food and Drug Administration
U.S. Food and Drug Administration
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
_how-is-my-medical-device-classified.webp "U.S. Food and Drug Administration")
_fda-101-for-medical-devices.webp "Registrar Corp")
_frances-richmond-risk-assessment-and-management-tools-part-1.webp "Frances Richmond, PhDnProfessor and Director, Regulatory Science ProgramnClinical Pharmacy and Pharmaceutical Economics and PolicynnIn this second session, Dr. Frances Richmond introduces us to the concepts of Risk Assessment and Management Tools as formal processes within the Regulatory framework we should all be aware of as clinical translational researchers who work with FDA approved drug or devices. Interestingly, she comments that these important regulatory strategies are “not particularl")
_fda-regulation-of-medical-devices-and-software-apps.webp "Fast Forward Medical Innovation – Commercialization Education")
_frances-richmond-risk-assessment-and-management-tools-part-2.webp "Frances Richmond, PhDnProfessor and Director, Regulatory Science ProgramnClinical Pharmacy and Pharmaceutical Economics and PolicynnIn this second session, Dr. Frances Richmond introduces us to the concepts of Risk Assessment and Management Tools as formal processes within the Regulatory framework we should all be aware of as clinical translational researchers who work with FDA approved drug or devices. Interestingly, she comments that these important regulatory strategies are “not particularl")
_risk-basics-for-medical-devices.webp "U.S. Food and Drug Administration")
_medical-device-regulations-fda-approval.webp "The BME Life")
_the-invasion-of-medical-mobile-apps-a-5-year-outlook.webp "Digital health is a fast-growing space and will shape medical technology innovation of the future. This is an overview about the trends in mobile medical apps today and in the next 5 years. The topics discussed in this lecture include:nn1. The rise of digital health and impact on healthcaren2. Early FDA-approved mobile medical devicen3. Trends in 2014 and 2015n4. Best mobile medical apps in 2014 and 2015n5. Market growth and where the technology is headingn6. Evaluation of medical mobile app cat")
_how-is-my-medical-device-classified.jpg)
_fda-101-for-medical-devices.jpg)
_frances-richmond-risk-assessment-and-management-tools-part-1.jpg)
_fda-regulation-of-medical-devices-and-software-apps.jpg)
_frances-richmond-risk-assessment-and-management-tools-part-2.jpg)
_risk-basics-for-medical-devices.jpg)
_medical-device-regulations-fda-approval.jpg)
_the-invasion-of-medical-mobile-apps-a-5-year-outlook.jpg)
![[+]](/images/menu.gif){kind=small}